Lyka Labs Ltd vs Rubicon Research Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 11, 2026

Key Highlights

The Latest Trading Price of Lyka Labs Ltd is ₹ 68.96 as of 11 Jun 15:30 . The P/E Ratio of Lyka Labs Ltd changed from 10 on March 2022 to 45.1 on March 2025 . This represents a CAGR of 45.73% over 4 yearsThe P/E Ratio of Rubicon Research Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Lyka Labs Ltd changed from ₹ 74.59 crore on March 2021 to ₹ 360.29 crore on March 2025 . This represents a CAGR of 37.02% over 5 yearsThe Market Cap of Rubicon Research Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Lyka Labs Ltd for the Mar '26 is ₹ 28.64 crore as compare to the Dec '25 revenue of ₹ 31.89 crore. This represent the decline of -10.19% The revenue of Rubicon Research Ltd for the Mar '26 is ₹ 516.53 crore as compare to the Dec '25 revenue of ₹ 479.32 crore. This represent the growth of 7.76% The ebitda of Lyka Labs Ltd for the Mar '26 is ₹ -5.84 crore as compare to the Dec '25 ebitda of ₹ 2.81 crore. This represent the decline of -307% The ebitda of Rubicon Research Ltd for the Mar '26 is ₹ 121.31 crore as compare to the Dec '25 ebitda of ₹ 111.91 crore. This represent the growth of 8.4% The net profit of Lyka Labs Ltd changed from ₹ 1.29 crore to ₹ -8.07 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Rubicon Research Ltd changed from ₹ 25.57 crore to ₹ 76.79 crore over 8 quarters. This represents a CAGR of 73.30% The Dividend Payout of Lyka Labs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Rubicon Research Ltd changed from -1.5 % on March 2023 to 0.18 % on March 2025 . This represents a CAGR of NaN% over 3 years .

About Lyka Labs Ltd

Initially manufacturing formulations, Lyka Labs Limited brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. '83.
It also added a range of ayurvedic and animal health care products over the years.
In 1990, it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson, US; Airsep Corporation, US; Coloplast, Denmark; and Terumo Corporation, Japan.
Lyka Exports is the subsidiary of the company.
The Company is engaged in the development, manufacture and marketing of quality finished dosages. The company offers a broad range of antibiotics used as life-savers and to treat minor infections.

About Rubicon Research Ltd

Rubicon Research Limited was incorporated on May 6, 1999, as a Private Company as Rubicon Consultants Private Limited', with the RoC. Subsequently, the Company's name was changed from Rubicon Consultants Private Limited' to Rubicon Research Private Limited' to which a fresh Certificate of Incorporation was issued by the RoC dated September 2, 2002.
The Company's status got converted from a Private Company to a Public Company, the name was changed from Rubicon Research Private Limited' to Rubicon Research Limited'.
A fresh Certificate of Incorporation dated July 23, 2024 was issued by the Central Processing Centre, Manesar, Haryana. Rubicon Research is an integrated pharmaceutical company with business encompassing the entire value chain in the research, development and production of pharmaceutical products.

FAQs for the comparison of Lyka Labs Ltd and Rubicon Research Ltd

Which company has a larger market capitalization, Lyka Labs Ltd or Rubicon Research Ltd?

Market cap of Lyka Labs Ltd is 246 Cr while Market cap of Rubicon Research Ltd is 21,214 Cr

What are the key factors driving the stock performance of Lyka Labs Ltd and Rubicon Research Ltd?

The stock performance of Lyka Labs Ltd and Rubicon Research Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lyka Labs Ltd and Rubicon Research Ltd?

As of June 11, 2026, the Lyka Labs Ltd stock price is INR ₹68.96. On the other hand, Rubicon Research Ltd stock price is INR ₹1287.7.

How do dividend payouts of Lyka Labs Ltd and Rubicon Research Ltd compare?

To compare the dividend payouts of Lyka Labs Ltd and Rubicon Research Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.